Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
1.4.2 Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type
3.1 Asia Pacific Aneuploidy Market by Country
3.2 Asia Pacific Chromosomal Abnormalities Market by Country
3.3 Asia Pacific X-linked diseases Market by Country
3.4 Asia Pacific Single Gene Disorders Market by Country
3.5 Asia Pacific HLA Typing Market by Country
3.6 Asia Pacific Gender selection Market by Country
3.7 Asia Pacific Other Test Type Market by Country
Chapter 4. Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Country
4.1 China Preimplantation Genetics Diagnosis (PGD) Market
4.1.1 China Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.2 Japan Preimplantation Genetics Diagnosis (PGD) Market
4.2.1 Japan Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.3 India Preimplantation Genetics Diagnosis (PGD) Market
4.3.1 India Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.4 South Korea Preimplantation Genetics Diagnosis (PGD) Market
4.4.1 South Korea Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.5 Singapore Preimplantation Genetics Diagnosis (PGD) Market
4.5.1 Singapore Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.6 Malaysia Preimplantation Genetics Diagnosis (PGD) Market
4.6.1 Malaysia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
4.7 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market
4.7.1 Rest of Asia Pacific Preimplantation Genetics Diagnosis (PGD) Market by Test Type
Chapter 5. Company Profiles
5.1 Illumina, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.2 Invitae Corporation
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expenses
5.3 Natera Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expenses
5.4 Agilent Technologies, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent Strategies and Developments:
5.4.5.1 Approvals and Trials:
5.5 PerkinElmer, Inc.
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expense
5.5.5 Recent Strategies and Developments:
5.5.5.1 Product Launches and Product Expansions:
5.6 Quest Diagnostics Incorporated
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental Analysis
5.7 Reproductive Genetic Innovations
5.7.1 Company Overview
5.8 PacGenomics
5.8.1 Company Overview
5.9 CeGaT GmbH
5.9.1 Company Overview
5.10. Laboratory Corporation of America Holdings
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
Unique Offerings 